Pten regulates homeostasis and inflammation-induced migration of myelocytes in zebrafish by Zhi-Wei Dong et al.
JOURNAL OF HEMATOLOGY
& ONCOLOGY
Dong et al. Journal of Hematology & Oncology 2014, 7:17
http://www.jhoonline.org/content/7/1/17RESEARCH Open AccessPten regulates homeostasis and inflammation-
induced migration of myelocytes in zebrafish
Zhi-Wei Dong1, Chun-Guang Ren1, Yu Xia1, Dan Su1, Ting-Ting Du2, Hong-Bo Fan1, Hao Yuan2, Lei Wang1,
Mei Dong1, Wei-Chun Li1, Yi Jin2, Yi Chen2, Min Deng1, Ting-Xi Liu1, Ai-Hua Gu3* and Yong Zhou1*Abstract
Background: Loss of the tumor suppressor phosphatase and tensin homolog (PTEN) is frequently observed in
hematopoietic malignancies. Although PTEN has been implicated in maintaining the quiescence of hematopoietic
stem cells (HSCs), its role in hematopoiesis during ontogeny remains largely unexplored.
Methods: The expression of hematopoietic marker genes was analyzed via whole mount in situ hybridization assay
in ptena and ptenb double mutant zebrafish. The embryonic myelopoiesis was characterized by living imaging and
whole mount in situ immunofluorescence with confocal microscopy, as well as cell-specific chemical staining for
neutrophils and macrophages. Analyses of the involved signaling pathway were carried out by inhibitor treatment
and mRNA injection.
Results: Pten-deficient zebrafish embryos exhibited a strikingly increased number of myeloid cells, which were
further characterized as being immune deficient. In accordance with this finding, the inhibition of phosphoinositide
3-kinase (PI3K) or the mechanistic target of rapamycin (mTOR) corrected the expansive myelopoiesis in the pten-deficient
embryos. Further mechanistic studies revealed that the expression of cebpa, a critical transcription factor in
myeloid precursor cells, was downregulated in the pten-deficient myeloid cells, whereas the injection of cebpa
mRNA markedly ameliorated the dysmyelopoiesis induced by the loss of pten.
Conclusions: Our data provide in vivo evidence that definitive myelopoiesis in zebrafish is critically regulated by
pten via the elevation of cebpa expression.
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Phosphatase and tensin homolog deleted on chromosome
10 (PTEN) is a well-characterized tumor suppressor gene,
and PTEN deficiency is frequently observed in various types
of cancers, including brain cancer, breast cancer, prostate
cancer, endometrial carcinoma, melanoma, and leukemia.
Indeed, PTEN is one of the most commonly mutated
genes in human cancers [1-3], and germline mutations
in PTEN are considered to be responsible for Cowden
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unless otherwise stated.Duclose disease [4]. In addition, PTEN has been shown
to regulate a series of fundamental cell behaviors, in-
cluding cell growth, proliferation, survival, and migra-
tion, mainly by suppressing the activity of the PI3K/
AKT pathway [5].
Conditional ablation of Pten in the hematopoietic stem
cells (HSCs) of adult mice leads to rapid HSC depletion
and the formation of leukemia-initiating cells (LICs) [6,7].
A recent study further showed that the mechanistic target
of rapamycin (mTOR) activation upon Pten deletion is crit-
ical during rapid HSC depletion [8]. Moreover, mTOR
complex 1 (mTORC1) is also required to sustain normal
hematopoiesis [9,10].
CCAAT enhancer-binding protein-α (C/EBPα) is another
tumor suppressor that can inhibit cell proliferation [11,12],td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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loid leukemia (AML) patients [13-16]. C/ebpα-deficient
mice show a phenotype similar to AML in which the tran-
sition from the common myeloid progenitor to the gran-
ulocyte/monocyte progenitor is blocked [17,18]. In fact,
C/EBPα plays a vital role in myeloid differentiation by
directly enhancing the transcription of many myeloid-
specific genes [19-22]. Our previous in vitro study showed
some relation between PTEN and CEBPA in HL-60 cell
line (derived from a patient with acute promyelocytic
leukemia) [23], but their interactive mechanism under-
lying the early hematopoiesis in vivo still remains elusive.
Over the past two decades, the zebrafish has emerged as
an ideal system for studying hematopoiesis owing to its
unique advantages, including optical clarity and a high fe-
cundity [24,25]. Similar to mammals, hematopoiesis in zeb-
rafish consists of two successive waves: primitive and
definitive hematopoiesis. Primitive hematopoiesis predom-
inantly produces primitive erythrocytes and macrophages,
whereas definitive hematopoiesis gives rise to all mature
hematopoietic lineages. In zebrafish, the latter process is
initiated in the ventral wall of the dorsal aorta, which
is counterpart of the aorta-gonad-mesonephros (AGM)
region in mammals. The hematopoietic stem/progenitor
cells (HSPCs) derived from the AGM migrate to caudal
hematopoietic tissue (CHT), which is similar to the fetal
liver in mammals. Lastly, HSPCs colonize the kidney mar-
row, which is the equivalent of bone marrow in mammals,
and the thymus to sustain long-term hematopoiesis
throughout adulthood [25-27].
Two pten genes, ptena and ptenb, have been previ-
ously identified in zebrafish [28]. Although ptena and
ptenb single mutants are able to survive to sexual matur-
ity because of the overlapping functions of these genes
[29]. Ptena and ptenb double mutants die approximately
5 days post fertilization (dpf) and exhibit significant
hyperplastic-dysplastic phenotypes (enlarged head and
heart edema. et al.) [29]. Accordingly, homozygous dele-
tion of Pten in mice is embryonic lethal [30]. Although
several elegant reports have established the pivotal role
of PTEN in preventing leukemogenesis [6,7,10], in vivo
evidence for PTEN regulation of hematopoiesis in early
development is lacking, and the detailed mechanism
underlying this process is still largely unknown.
In this study, we investigated the physiological role of
pten signaling in hematopoiesis by utilizing pten mutant
zebrafish. We tried to explore the influence of complete
loss of pten on primitive hematopoiesis, the developmental
process and the innate immune response of myeloid cells
in definitive hematopoiesis, and the regulational effects of
the PI3K/mTOR pathway involved. Furthermore, we re-
vealed the intriguing function of overexpression of C/ebpα
in the hematopoietic defect of pten mutant embryos by act-
ing downstream of the PI3K pathway.Results
Loss of pten induces abnormal hematopoiesis in
zebrafish larvae
To evaluate the role of pten in hematopoiesis, we exam-
ined the expression of critical hematopoietic genes in
pten-deficient zebrafish by using whole-mount in situ
hybridization analysis.
We first examined hematopoiesis in ptena and ptenb
single-mutant embryos and found no obvious alteration in
hematopoiesis (data not shown). We then examined
the hematopoietic phenotypes in ptena and ptenb
double-mutant (ptena−/−ptenb−/−, hereafter referred
to as pten−/−) embryos, which were derived from an
incross of ptena+/−ptenb−/− (hereafter referred to as
pten+/−) zebrafish. Both primitive hematopoiesis at
22 hours post-fertilization (hpf ) (Additional file 1:
Figure S1A-H) and definitive hematopoiesis at 36 hpf
and 48 hpf (Additional file 1: Figure S1I-P) were nor-
mal in the pten−/− embryos.
However, in comparison to the control embryos, the
pten−/− embryos at 90 hpf showed an obvious increase
in the number of cmyb-expressing and scl-expressing
HSPCs in the CHT (Additional file 1: Figure S2A-D). Of
note, a significant increase in the number of α-E1 glo-
bin-expressing mature erythrocytes that were ectopically
dispersed in the head and yolk sac of the pten−/− em-
bryos was observed, although only subtle expansion was
noted in the CHT (Additional file 1: Figure S2E-F), the
major region colonized by mature erythrocytes in con-
trol embryos.
We observed that definitive myelopoiesis in the pten−/−
embryos was significantly increased at 90 hpf, as indicated
by the enhanced expression of lyz (a myeloid marker) in
both the CHT and kidney region (Figure 1A-B and E), and
we also confirmed expansive myelopoiesis in the pten−/−;
lyz:EGFP embryos [31] (Figure 1C-D and F). Furthermore,
we examined other markers of myeloid cells (l-plastin,
mpo, and nephrosin) in addition to lyz and found that their
expression levels were also increased in the CHT at 90 hpf
(Figure 1G-M), indicating that pten signaling is essential for
normal definitive myelopoiesis. To further characterize
the developmental process of abnormal myelopoiesis
in pten−/− fish, we performed whole-mount in situ
hybridization for lyz every 6 hours, from 72 to 108 hpf
(Additional file 1: Figure S3A-N and Q). The whole-mount
in situ hybridization results showed that abnormal myelo-
poiesis appeared as early as 78 hpf (Additional file 1: Figure
S3A-D) and lasted for approximately 15 hours until the
myeloid cells became scattered along the upper edge of the
yolk sac at approximately 96 hpf (Additional file 1: Figure
S3C-J). Lastly, the myeloid cells of the pten−/− embryos be-
came much more dispersed, and their number decreased to
a level comparable to that of the controls (Additional file 1:
Figure S3K-N), which is likely due to enhanced apoptosis
Figure 1 Definitive myelopoiesis is strongly expansive in pten-deficient embryos. (A-B) Whole-mount in situ hybridization analyses of definitive
myelopoiesis with riboprobes for lyz in the indicated embryos at 90 hpf. The lower panels are high-magnification views of the indicated region in the
upper panel. The red arrowheads indicate myeloid cells in the CHT and kidney/thymus region. (C-D) The pten−/−;lyz:EGFP embryos show increased
EGFP-positive myeloid cells. The red arrowheads indicate EGFP-positive cells in the CHT and kidney region. The embryos are shown in lateral views
with the anterior to the left. e: eye. (E-F) Statistical result for a, b and c, d respectively. (G-M) Whole-mount in situ hybridization analyses for other
myeloid markers (l-plastin, mpo, nephrosin) in the CHT. The red arrowheads indicate the myeloid cells marked by each probe. The data shown in (E-F)
and (M) are the means ± SEM of at least 30 embryos; ***p < 0.001 versus the control. Scale bar: 100 um.
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be noticed that apoptosis is not limited to lyz-positive cells
(Additional file 1: Figure S3P). This may be due to the rap-
idly deteriorated health of pten−/− fish with faint heart
beating, smaller eyes and enlarged head from 4 to 5 dpf. In
fact, pten−/− embryos only had slightly visible abnormality
(subtle heart edema) at 90 hpf when most of our assays
were performed. Thus, the marked changes at late stage
hardly impacted on our observation in myelopoiesis.
Taken together, these results demonstrate that a defi-
ciency in pten signaling induces abnormal hematopoiesis,
particularly the abnormal expansion of definitive myeloid
cells, in zebrafish.
Expansive myelopoiesis in pten−/− embryos is due to
reduced apoptosis and block in myeloid cell maturation
To determine whether the relatively expansive myelopoi-
esis in pten−/− embryos can be attributed to the en-
hanced myeloid cell proliferation, we performed double
staining in pten−/−;lyz:EGFP embryos using antibodies
against phospho-histone 3 (PH3) and EGFP. There was no
significant difference in the proliferation of lyz-positive
myeloid cells between the pten−/− and control embryos
(Additional file 1: Figure S4A-F and M). In addition, no ob-
vious changes in the proliferation of HSPCs was observed
in the pten−/− embryos, as evidenced by the co-staining of
PH3 and EGFP in pten−/−;cmyb:EGFP larvae (Additional
file 1: Figure S4G-L and N).
Notably, the number of myeloid cells in the control
embryos at 90 hpf was significantly lower than that at 80
hpf; however, the myeloid cell number in the pten−/−
embryos at 90 hpf was almost the same with that at 80
hpf (Additional file 1: Figure S3, the second and the
forth value on the dashed line, both of which is about
170). We hypothesized that the expansion of myeloid
cells was due to the relative reduction in apoptosis in the
pten−/− embryos. To test this possibility, a terminal trans-
ferase UTP nick end-labeling (TUNEL) assay was per-
formed at 80 hpf when the lyz-positive cells in pten−/−
zebrafish just started to increase. Indeed, fewer apoptotic
myeloid cells were observed in the pten−/− embryos com-
pared to the control embryos, suggesting that reduced
apoptosis in the pten−/− embryos may partially contribute
to the observed expansive myelopoiesis.
Considering that the block in maturation could also
contribute to an increased number of myeloid cells, we
next examined the morphology of the myeloid cells by
performing Wright-Giemsa staining of FACS-purified
EGFP-positive cells from pten−/−;lyz:EGFP and control
embryos at 90 hpf. The nuclei of the control myeloid
cells exhibited a typical kidney shape, which is indica-
tive of mature neutrophils (Figure 2H). However, the
nuclei of the pten−/− myeloid cells exhibited a high
nucleus-to-cytoplasm ratio and loose chromatin, whichare features of metamyelocytes and promonocytes
(Figure 2I). These data suggest that neutrophil matur-
ation is blocked at the metamyleocytic stage in the
pten−/− embryos.
To further confirm the reduction in mature neutro-
phils, we performed whole-mount in situ staining utiliz-
ing Sudan Black B, which specifically stains the granules
of granulocytes [32,33]. The control embryos typically
showed heavily stained neutrophils in the CHT, whereas
only lightly stained cells were detected in the pten−/−
embryos (Figure 2J-L). This result indicated that the
maturation of neutrophils was severely blocked upon
pten loss during definitive myelopoiesis.
Collectively, our results suggest that the observed ex-
pansive myelopoiesis in pten−/− embryos is due to the
inhibition of myeloid maturation and a modest blockage
of apoptosis.
Loss of pten impairs the immune response of myeloid cells
Because the immune response of myeloid cells is import-
ant in the early development of zebrafish [31,34-37], we
evaluated the ability of these cells to respond to inflam-
mation in pten−/− embryos. Tail transections near the
caudal circulatory system of pten−/−;lyz:EGFP and con-
trol embryos at 84 hpf were performed as previously de-
scribed [31,37]. Six hours later, the directional migration
of EGFP-positive cells toward the acute injury induced
by the tail transections was observed by fluorescence
microscopy. Compared to the control embryos, the
number of EGFP-positive cells in the pten−/− embryos
that migrated to the injury site was remarkably reduced
(Figure 3A-C), particularly in the region close to the wound
(Figure 3A-B, rightmost areas of the lower panels).
Additionally, more EGFP-positive cells in the region far
from the wound were unable to migrate to the injury
site (Figure 3B, leftmost areas of the lower panels,
Additional file 2: Movie S1 and Additional file 3: Movie
S2). Furthermore, the increased total number of EGFP-
positive myeloid cells in pten−/− embryos (Figure 3D)
enhanced the immune-deficiency of the myeloid cells in
pten−/− embryos, with a lower percentage of migration
neutrophils (Figure 3E).
To specifically assess the immune response of macro-
phages in the pten−/− embryos, we performed Neutral
Red staining by incubating zebrafish larvae in staining
buffer from 80 to 90 hpf. Intriguingly, more heavily stained
macrophages were observed in the CHT of pten−/− em-
bryos compared to the control embryos, suggesting that the
pten-deficient macrophages take up relatively more Neutral
Red (Figure 3F-G and J). We also performed whole-mount
in situ hybridization with c-fms, a specific marker for
macrophages. Our result indicated that the number of mac-
rophages was greatly increased in pten−/− embryos com-
pared to controls (Figure 3H-I and K), which is consistent
Figure 2 Reduced apoptosis and block in myeloid cell maturation underlie pten deficiency-induced expansive myelopoiesis. (A-G)
Double staining of lyz-driven EGFP protein and TUNEL assay in the CHT of control and pten−/− embryos at 80 hpf. Although relative more EGFP-positive
myeloid cells were observed in the pten−/− embryos (A and B, all green cells were manually counted as positive), few cells were simultaneously apoptotic,
as indicated by merging with TUNEL staining (E and F, white arrowheads). (H and I) Wright-Giemsa staining and morphological characterization of FACS-
purified EGFP-positive cells from 90 hpf pten−/−;lyz:EGFP and control embryos. The black arrowheads indicate the nuclear shape, which was typically
kidney-like and condensed in control embryos (H) but remained in a loose state in the pten−/− embryos (I). (J-L) Sudan Black staining of neutrophils at 90
hpf. The red arrowheads indicate neutrophils in the CHT. The data shown in (G) and (L) are the means ± SEM of at least 15 and 30 embryos; ***p < 0.001
versus the control. Scale bar: h and i, 5 um; others, 100 um.
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tively more macrophages were produced upon pten loss.
Collectively, these results demonstrate that the normal
immune response of myeloid cells is severely impaired dur-
ing definitive myelopoiesis in pten−/− zebrafish embryos.
The PI3K/mTOR pathway contributes to pten deficiency-
induced dysmyelopoiesis
It is well known that PTEN plays a major role in the
regulation of cell survival, metabolism, and migration by
negatively regulating PI3K signaling [4]. We therefore
hypothesized that the expansive myelopoiesis in pten−/−
fish may be rescued by treatment with specific inhibitors
of PI3K signaling, such as LY294002. To test this hy-
pothesis, pten−/− embryos were treated with LY294002
from 78 hpf to 90 hpf at concentrations of 5, 15, and
30 μM. Whole-mount in situ hybridization analysesshowed that LY294002 rescued expansive myelopoiesis
in both the CHT and kidney region in a dose-
dependent manner (Figure 4A-F and M). Moreover,
the pten−/− embryos treated with 30 μM LY294002
displayed fewer myeloid cells than the controls (Figure
4A and F).
Because mTOR signaling could be activated by the ac-
tivation of the PI3K pathway [23,38,39], we also treated
pten−/− fish with rapamycin, a specific inhibitor of mTOR.
A similar dose-dependent rescue of expansive myelopoiesis
was also observed (Figure 4G-L and N).
To further explore whether the suppression of PI3K/
mTOR pathway could also abolish the block of neutro-
phil maturation upon pten loss, we performed Sudan
black assay on LY294002- and rapamycin-treated pten−/−
embryos (Figure 5A-F). As we speculated, the maturation
of neutrophils was largely recovered in LY294002- and
Figure 3 The immune response of expansive myeloid cells is impaired in pten−/− embryos. (A and B) Tail transection analyses of myeloid
cell movement in response to inflammation. The myeloid cells of the control and pten−/− embryos moved to the wound site at 6 hours
post-transection (hpt) (90 hpf) (A and B, white boxes). The red arrowheads indicate the myeloid cells away from the wound (A and B, left region of the
lower panels) and the myeloid cells that arrived at the wound (A and B, right region of the lower panels). A white asterisk indicates the heart edema of
pten−/− embryos. (C-E) Quantification of myeloid cells in the region to the right of the white dashed line (A and B, lower panel) (C) and the total number
of myeloid cells (D) in each embryo. (E) The percentage of myeloid cells that migrated to the wound. (F and G) Neutral Red staining of macrophages at
90 hpf. The black arrowheads indicate macrophages in the CHT. (H and I)Whole-mount in situ hybridization analyses of macrophages with riboprobe for
c-fms. The black arrowheads indicate macrophages in the CHT. (J and K) Statistical results of F, G and H, I respectively. The data shown are the means ±
SEM of at least 30 embryos; ***p < 0.001 versus the control. Scale bar: 100 um.
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compared to mock-treated ones (Figure 5A and G).
We have shown that the maturation of neutrophils
was blocked upon pten loss, which may imply that the
rescue effects of LY294002 and rapamycin occurred in
a cell-autonomous manner, a question need to be fur-
ther addressed. To selectively antagonize PI3K/mTOR
signaling in the myeloid cells of pten−/− embryos, we
transiently expressed zebrafish pten (ptena and ptenb) byTol2-mediated gene transfer using lyz promoter (Additional
file 1: Figure S5). As predicted, pten−/− embryos with tran-
siently expressed myeloid pten show less lyz-positive mye-
loid cells (Additional file 1: Figure S5D) compared to
control embryos (Additional file 1: Figure S5C and E).
Taken together, our data indicate that the abnormal
activation of the PI3K/mTOR pathway resulting from
the deficiency of pten contributes to the expansive dys-
myelopoiesis observed in pten−/− zebrafish embryos.
Figure 4 The PI3K/mTOR pathway contributes to the expansion of definitive myelopoiesis in pten−/− embryos. (A-L) Whole-mount in
situ hybridization analyses of lyz-positive myeloid cells in embryos treated with increasing doses of LY294002 (LY) or rapamycin (Ra) at 90 hpf.
Untreated and mock-treated pten−/− embryos (B, C and H, I) showing expansive myelopoiesis compared to the controls (A and G), as mentioned
above. The pten−/− embryos treated with stepwise increases in LY294002 or rapamycin showed an obvious rescue effect, as indicated by the decrease in
myeloid cells (D-F and I-L). The red arrowheads indicate the main positions of the myeloid cells. (M and N) Quantification of myeloid
cells in each embryo (a-l). The data shown are the means ± SEM of at least 30 embryos, *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding
controls. Scale bar: 100 um.
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of pten
Our previous study indicated that C/EBPα could regu-
late myeloid development downstream of PTEN. Ele-
vated expression of PTEN could promote the expression
of CEBPA in HL-60 cell line [23]. Moreover, C/EBPα is
a well-known master regulator of myelopoiesis [40]. To
further elucidate the role of C/ebpα in pten deficiency-induced expansive myelopoiesis, we performed real-time
quantitative PCR to evaluate the expression level of
cebpa in EGFP-positive myeloid cells isolated from
pten−/−;lyz:EGFP embryos at every 6 hours between 72
and 102 hpf. In contrast to the gradually increasing
number of lyz-positive myeloid cells in the pten−/− em-
bryos (Additional file 1: Figure S3A-L) from 72 to 102
hpf (Figure 6A, dashed line and the right Y axes), the
Figure 5 The PI3K/mTOR pathway contributes to the blockage of myeloid cell maturation in pten−/− embryos. (A-F) Sudan Black
staining of neutrophils at 90 hpf. Control and pten−/− embryos were treated with DMSO (A-B) or LY294002/Rapamycin (C-D and E-F) at
indicated concentration. The red arrowheads indicate neutrophils in the CHT. (G) statistical results of A-F. The data shown in (G) are the
means ± SEM of at least 30 embryos; ***p < 0.001 versus the control. Scale bar: 100 um.
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cells gradually decreased (Figure 6A, solid line and the
left Y axes).
The downregulation of cebpa may contribute to expan-
sive myelopoiesis in the pten−/− embryos. We therefore
microinjected cebpa mRNA into one-cell-stage pten−/−
embryos and then performed whole-mount in situ
hybridization analyses on the injected embryos using a
probe for lyz at 90 hpf. Compared to the mock-injected
pten−/− embryos (Figure 6D), the number of lyz-posi-
tive myeloid cells significantly decreased in the pten−/−
embryos injected with cebpa mRNA (Figure 6E and J),
suggesting that C/ebpα functions downstream of pten to
regulate the homeostasis of definitive myelopoiesis.
To further determine the functional consequences of
cebpa overexpression, we performed Sudan black staining
on cebpa mRNA-injected pten−/− embryos (Figure
6F-I). Our result showed that the number of mature
neutrophils was obviously rescued in pten−/− embryos
injected with cebpa mRNA (Figure 6I), in contrast to
the mock-injected ones (Figure 6H and K). These data
suggested that overexpression of cebpa mRNA couldabolish the block in neutrophil maturation induced by
pten-dificiency.
We next examined whether the PI3K/mTOR pathway
was involved in the contribution of C/ebpα to expansive
myelopoiesis. To test this possibility, real-time quanti-
tative PCR was performed to detect the expression level
of cebpa in lyz-positive myeloid cells treated with LY294002
or rapamycin. Surprisingly, the elevated expression of cebpa
was observed only in the LY294002-treated embryos
(Additional file 1: Figure S6), suggesting that C/ebpα
functions downstream of pten in a PI3K-dependent,
mTOR-independent manner.
Collectively, our results demonstrate that the down-
regulation of cebpa by the PI3K pathway contributes to
pten deficiency-induced expansive myelopoiesis.
Discussion
More than a decade of work has been performed to exam-
ine the role of PTEN, which is a frequently mutated tumor
suppressor gene [41]. In this study, we investigated the role
of pten in the developmental process of hematopoietic line-
ages, which has not been fully characterized. Our data
Figure 6 The overexpression of C/ebpα ameliorates expansive myelopoiesis in pten-deficient embryos. (A) The expression level of cebpa
was negatively related to the number of myeloid cells. Real-time quantitative PCR of cebpa in EGFP-positive myeloid cells from pten−/−;lyz:EGFP
and control embryos was performed every 6 hours from 72 to 102 hpf (solid line and left Y-axis). The lyz-positive myeloid cells in each embryo
were counted via the whole-mount in situ hybridization analyses of embryos at 72 to 102 hpf (dashed line and right Y-axis). The indicated value
is the ratio of pten−/− to control myeloid cells. (B-E) Whole-mount in situ hybridization analyses for lyz in embryos injected with in vitro-synthesized
control (B and C) or cebpa (D and E) mRNA at the one-cell stage. The overexpression of cebpa mRNA largely rescues expansive myelopoiesis in pten−/−
embryos. The red arrowheads indicate expansive myelopoiesis in the mock-injected pten−/− embryos and the decrease in myeloid cells in the cebpa-
injected pten−/− embryos. (F-I) Sudan Black staining of neutrophils in embryos injected with control (F and H) or cebpa (G and I) mRNA. The red
arrowheads indicate neutrophils in the CHT. (J and K) Quantification of myeloid cells in each embryo (B-E and F-I). The data shown are the means ±
SEM of at least 30 embryos; *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding controls. Scale bar: 100 um.
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hematopoiesis, particularly myelopoiesis. Importantly, we
determined that immune-deficient cells are produced dur-
ing the expansive myelopoiesis caused by the loss of pten.
Moreover, this expansive myelopoiesis could be completely
rescued by treatment with inhibitors of the PI3K/mTORpathway. Additionally, we found that the expression of
cebpa is regulated by PTEN/PI3K signaling and that cebpa
downregulation contributes to the expansive myelopoiesis
induced by pten deficiency. Collectively, our results help to
elucidate the previously obscure role of pten in zebrafish
myelopoiesis and the innate immune response in addition
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of pten in the regulation of myelopoiesis.
Our previous report indicated that ptenb morphants
develop myelodysplasia during primitive hematopoiesis
[23]; however, this was not observed in our ptenb and
pten−/− mutants (data not shown and Additional file 1:
Figure S1). This discrepancy may be due to the toxicity
of the morpholino and/or cross-reactions of the ptenb
morpholino with other unknown transcripts. Nonethe-
less, we did observe abnormal hematopoiesis at a later
stage (90 hpf) in the pten−/− embryos, which further con-
firmed the indispensability of pten in hematopoiesis. The
most striking phenotype that we observed in the pten−/−
embryos was expansive myelopoiesis (Figure 1A-B and E),
which was specific to the developmental stage and could
not be detected at 72 hpf (Additional file 1: Figure S3A-B),
as indicated by the whole-mount in situ hybridization stain-
ing of lyz. Considering that our pten−/− embryos were ob-
tained by incrossing ptena+/−ptenb−/− fish, the maternal
contribution of ptena [42] might have contributed to the
developmental stage-specific occurrence of expansive mye-
lopoiesis, which might no longer be observable, when the
maternal influence of ptena eventually dissipates.
Despite the relative increased staining of HSPCs
(Additional file 1: Figure S2A-D), we observed dis-
persed erythrocytes in the head region (Additional file
1: Figure S2E-F), which might have been caused by vas-
cular and/or circulation defects [43].
Similar to mammals, zebrafish myeloid cells (mainly
neutrophils and macrophages) are important partners
of the innate immune system [33,36,44]. However, the
exact function of pten in myeloid cells has remained un-
clear. In mice, Pten was first highlighted as a suppressor
of myeloid cell migration [45]. Conversely, another study
indicated that Pten functioned to promote neutrophil in-
flux during inflammation [46]. Our results clearly show that
pten is indispensable for the maturation of neutrophils, en-
suring normal migration during the inflammation induced
by acute injury (Figure 2J-L and Figure 3A-C). Interestingly,
a recent study indicated that Pten loss could arrest differen-
tiation, which may help to explain impaired immune func-
tion of myelocytes [47]. Moreover, our data also suggest
that the means by which pten regulates macrophage func-
tion are largely different from the means by which it regu-
lates neutrophils, as more Neutral Red absorption was
observed in the relatively more macrophages of the pten
deficient embryos but almost no mature neutrophils was
observed in these embryos (Figure 3F-G and Figure 2J-L).
Although the phagocytosis ability of pten−/− macrophages
might be greatly elevated, which was previously indicated
in ex vivo murine peritoneal and alveolar macrophages
[48-50], other possibilities should not be excluded. For ex-
ample, pten−/− macrophages might be less intact and in
turn could easily be saturated by Neutral Red. A morecritical functional assay of pten−/− macrophages may help
to clarify this issue.
In addition to the characterization of expansive myelo-
poiesis and the impaired immune response of myeloid
cells induced by pten deficiency, this study also indicated
the contribution of C/ebpα and PI3K/mTOR signaling
in pten-regulated myelopoiesis (Figures 4, 5 and 6). In-
deed, the contribution of PI3K/mTOR signaling was
further clarified in our pten-deficient zebrafish model show-
ing expansive myelopoiesis (Figures 4 and 5), though the
possibility a PI3K-independent function of pten was respon-
sible for this phenotype could not be completely excluded.
Although non-specificity of LY294002 at high doses was re-
ported before [51] and this non-specificity was not easy to
assess, the increasing rescue effect of dysmyelopoiesis with
increasing dose of LY294002 could still support our conclu-
sion. In fact, no additional obvious abnormality was ob-
served in pten−/− fish treated with 30 μM LY294002
compared to mock treated ones. Our previous study indi-
cated that C/EBPα may act as a downstream effector of
PTEN in hematopoiesis [23]. Moreover, other study shown
that PTEN/PI3K signaling (through regulating eIF4E and
eIF2) could influence the expression of CEBPA [52].
Interestingly, our data strongly suggest that the elevated ex-
pression of cebpa could significantly ameliorate pten
deficiency-induced expansive myelopoiesis (Figure 6); how-
ever, more research is still needed to determine the detailed
mechanism of C/ebpα regulation via the pten pathway.
Our results also indicated that the regulation of C/
ebpα by pten is PI3K dependent and mTOR independent
though inhibition of the mTOR pathway could rescue
the expansive myelopoiesis induced by the loss of pten
(Additional file 1: Figure S6 and Figure 4G-L). This re-
sult is conceivable considering that the phosphorylation
of Akt at Ser 473 is also regulated in a PI3K-dependent,
mTOR-independent manner [53]. We propose that some
unknown factors that underlie pten deficiency-induced
expansive myelopoiesis might exist downstream of
mTOR. Nevertheless, our results suggest that both
mTOR-dependent and -independent mechanisms may
underlie pten-regulated myelopoiesis; clearly, these
mechanisms warrant further investigation.Conclusions
Our study reveals the developmental function of pten in
myelopoiesis and further dissects its role in the immune
response of myeloid cells. Our finding that C/ebpα acts
as a downstream effector of pten provides more inform-
ative clues regarding the intrinsic nature of pten-regu-
lated hematopoiesis. In addition, pten−/−;lyz:EGFP fish
are an ideal model for performing large-scale whole-
animal small molecule screening to identify drug candi-
dates that can ameliorate defects in myelopoiesis.
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Zebrafish maintenance and embryo production
Zebrafish maintenance, breeding, and staging were per-
formed as described previously [54]. The zebrafish facility
and zebrafish study were approved by the Institutional
Review Board of the Institute of Health Sciences.
Genomic DNA isolation and genotyping
Embryos or tail fins were incubated in lysis buffer (1 M
Tris–HCl [pH 8.3], 1 M KCl, 10% Tween 20, and 10%
NP40) and subsequently treated with proteinase K (10 mg/
ml) at 55°C overnight. After centrifuging at 12, 000 × g for
10 minutes at 4°C, the supernatant was subjected to gen-
omic PCR using primers specific for the indicated genes.
Riboprobe synthesis and whole-mount mRNA in situ
hybridization
Digoxigenin-labeled antisense RNA probes were tran-
scribed from linearized constructs using T3, T7, or SP6
polymerase (Roche Applied Science, Indianapolis, IN,
USA). Whole-mount mRNA in situ hybridization was
performed as described previously [55]. The probes were
detected using an alkaline phosphatase-coupled anti-
digoxigenin Fab fragment antibody (Roche Diagnostics,
Indianapolis, IN, USA) with 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium (BCIP/NBT) staining
(Vector Laboratories, Burlingame, CA).
Phosphorylated histone H3 labeling and TUNEL assay
TUNEL assays were performed using the In Situ Cell
Death Detection Kit and TMR Red (Roche Diagnostics)
according to the manufacturer’s recommendations. PH3
labeling of fixed embryos was performed by overnight
incubation with a rabbit anti-phosphohistone H3 anti-
body (Santa Cruz Biotechnology, Santa Cruz, CA, USA) at
4°C, followed by incubation with an Alexa Fluor 488 don-
key anti-rabbit secondary antibody (Invitrogen, Carlsbad,
CA, USA).
Flow cytometry analysis and cytology
lyz:EGFP and cmyb:EGFP transgenic embryos were dis-
sected and digested with 0.5% trypsin (GIBCO, Grand
Island, NY, USA) for 30 minutes at 37°C. A single-cell
suspension was obtained by centrifugation at 400 × g for
5 minutes, washing twice with PBS, and passing through a
40-μM nylon mesh filter. Fluorescence-activated cell
sorting (FACS) was performed using the MoFlo system
(DakoCytomation, Carpinteria, CA, USA) to obtain
homogenous EGFP + cells, which were subsequently
subjected to cytospinning at 40 × g for 5 minutes,
followed by Wright-Giemsa staining. The staining was
performed according to the manufacturer’s instruc-
tions (Sigma-Aldrich, UK). The micrographs were ob-
tained using a microscope (Nikon ECLIPSE 80i) with a100× oil immersion objective and Nikon ACT-1 soft-
ware (Nikon Corporation, JP).
Neutral Red and Sudan Black staining
For Neutral Red staining, embryos were collected and
incubated in egg water with 2.5 μg/mL Neutral Red
(Sigma-Aldrich) from 80 to 90 hpf [56]. For Sudan Black
staining, fixed embryos were treated with a Sudan Black
(Sigma-Aldrich) solution, as previously described [32].
Staining was then observed under a microscope.
Treatment of embryos with small molecule inhibitors
Small molecule inhibitors dissolved in dimethyl sulfoxide
(DMSO) were added to egg water as previously described
[29,57]. The concentrations of LY294002 and rapamycin
were 5–30 μM and 1–20 μM, respectively. Both inhibitors
were added at 78 hpf.
mRNA synthesis and microinjection
mRNA was synthesized using the mMessage mMachine
kit (Ambion, Austin, TX, USA). For the microinjection
experiment, a volume of 1 nL (30 ng/μL) was injected
into embryos at the one-cell stage.
Tol2-mediated gene transfer
The zebrafish lyz promoter was cloned into the EGFP-
2A-pDestTol2 plasmid at the XhoI and ClaI sites to get
the lyz-pDestTol2 construct. The zebrafish ptena and
ptenb were obtained by PCR from the cDNA of wild-
type embryos respectively, and then utilizing overlapping
PCR to get EGFP-2A-ptena/ptenb fragments which were
cloned into the lyz-pDestTol2 construct at the ClaI and
SalI sites to get the lyz-EGFP-2A-ptena/ptenb-pDestTol2
constructs. Then the lyz-EGFP-2A-pDestTol2 and lyz-
EGFP-2A-ptena/ptenb-pDestTol2 transgenic plasmids
(25 ng/μL) were individually co-injected with Tol2
transposase mRNA (25 ng/μL) as previously reported [58]
into the pten−/− or control embryos at one cell stage.
Real-time quantitative PCR
Total RNA was extracted from at least 5,000 FACS-sorted
cells using the Trizol reagent (Sigma-Aldrich). RNA was
reverse-transcribed using oligo (dT) and Superscript™ III re-
verse transcriptase (RT) (Invitrogen). The subsequent PCR
assay was performed with the SYBR Premix ExTaq kit
(Takara, JP) (sequence data are available upon request). The
relative expression values were normalized to the in-
ternal control (β-actin). The cDNA amplification was
performed using an ABI Prism 7900 HT cycler (Ap-
plied Biosystems, Foster City, CA, USA). Primers for
cebpa, 5′-CAAGCAAGAGAAGCTCAAAC, 5′-ACCG
TGGTGGTAGTCGTAG; for β-actin, 5′-TGCTGTTT
TCCCCTCCATTG, 5′-TTCTGTCCCATGCCAACCA.
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The quantitative data are expressed as the mean ± SEM.
The statistical significance was determined by a two-
tailed Student’s t-test (*p < 0.05, **p < 0.01, ***p < 0.001).
Additional files
Additional file 1: Figure S1. Primitive hematopoiesis and the early
stage of definitive hematopoiesis are normal in pten-/- embryos. Figure
S2. Definitive hematopoiesis is hampered in pten-/- embryos. Figure S3.
WISH analyses of lyz-positive myeloid cells from 72 to 108 hpf. Figure S4.
Dysmyelopoiesis induced by Pten loss is not due to the proliferation of
hematopoietic cells. Figure S5. Transiently expressed Pten in myeloid
cells ameliorates expansive myelopoiesis in pten-/- fish. Figure S6. The
expression level of cebpa is regulated by PI3K rather than the mTOR pathway.
Additional file 2: Movie S1. Movies were taken at about 88 hpf (4 hours
after tail transection) and lasted for half an hour. Wound was at the right side
of movies. Compared to control lyz:EGFP embryos.
Additional file 3: Movie S2. Movies were taken at about 88 hpf (4
hours after tail transection) and lasted for half an hour. Wound was at the
right side of movies. Most of the EGFP-positive myeloid cells in pten-/-
embryos showed little migration to the wound.
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